Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer

Manfredi, 2006, Epidemiology and management of liver metastases from colorectal cancer, Ann Surg, 244, 254, 10.1097/01.sla.0000217629.94941.cf Dixon, 2004, Strategies for palliative care in advanced colorectal cancer, Dig Surg, 21, 344, 10.1159/000081351 Eisenberger, 2008, Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review, Int J Colorectal Dis, 23, 559, 10.1007/s00384-008-0456-6 Scheer, 2008, Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases, Ann Oncol, 19, 1829, 10.1093/annonc/mdn398 Rosen, 2000, Initial presentation with stage IV colorectal cancer: how aggressive should we be?, Arch Surg, 135, 530, 10.1001/archsurg.135.5.530 Ruo, 2003, Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients, J Am Coll Surg, 196, 722, 10.1016/S1072-7515(03)00136-4 Galizia, 2008, First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases, Arch Surg, 143, 352, 10.1001/archsurg.143.4.352 Scoggins, 1999, Nonoperative management of primary colorectal cancer in patients with stage IV disease, Ann Surg Oncol, 6, 651, 10.1007/s10434-999-0651-x Sarela, 2001, Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer, Br J Surg, 88, 1352, 10.1046/j.0007-1323.2001.01915.x Tebbutt, 2003, Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases, Gut, 52, 568, 10.1136/gut.52.4.568 Michel, 2004, Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?, Gastroenterol Clin Biol, 28, 434, 10.1016/S0399-8320(04)94952-4 Benoist, 2005, Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases, Br J Surg, 92, 1155, 10.1002/bjs.5060 Muratore, 2007, Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy?, Ann Surg Oncol, 14, 766, 10.1245/s10434-006-9146-1 Evans, 2009, Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer, World J Surg Oncol, 7, 28, 10.1186/1477-7819-7-28 Poultsides, 2009, Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment, J Clin Oncol, 27, 3379, 10.1200/JCO.2008.20.9817 Karoui, 2007, Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration, Arch Surg, 142, 619, 10.1001/archsurg.142.7.619 Khot, 2002, Systematic review of the efficacy and safety of colorectal stents, Br J Surg, 89, 1096, 10.1046/j.1365-2168.2002.02148.x Carne, 2004, Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival, Dis Colon Rectum, 47, 1455, 10.1007/s10350-004-0624-x Fiori, 2004, Malignant intestinal obstruction: useful technical advice in self-expanding metallic stent placement, Anticancer Res, 24, 3153 Watt, 2007, Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review, Ann Surg, 246, 24, 10.1097/01.sla.0000261124.72687.72 van Hooft, 2008, Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer, Endoscopy, 40, 184, 10.1055/s-2007-995426 Hapani, 2009, Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis, Lancet Oncol, 10, 559, 10.1016/S1470-2045(09)70112-3 Karoui, 2008, Chemotherapy has also an effect on primary tumor in colon carcinoma, Ann Surg Oncol, 15, 3440, 10.1245/s10434-008-0167-9 Kabbinavar, 2005, Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer, J Clin Oncol, 23, 3706, 10.1200/JCO.2005.00.232 Grothey, 2008, Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE), J Clin Oncol, 26, 5326, 10.1200/JCO.2008.16.3212 Gruenberger, 2008, Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer, J Clin Oncol, 26, 1830, 10.1200/JCO.2007.13.7679 Van Cutsem, 2009, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer, N Engl J Med, 360, 1408, 10.1056/NEJMoa0805019 Stelzner, 2005, Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis, J Surg Oncol, 89, 211, 10.1002/jso.20196 Adam, 2004, Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg, 240, 644, 10.1097/01.sla.0000141198.92114.f6 Folprecht, 2005, Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates, Ann Oncol, 16, 1311, 10.1093/annonc/mdi246 Simmonds, 2006, Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies, Br J Cancer, 94, 982, 10.1038/sj.bjc.6603033 Nordlinger, 2008, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet, 371, 1007, 10.1016/S0140-6736(08)60455-9